Growth Metrics

Silence Therapeutics (SLN) Net Income Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.79%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 60.43%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -46.86%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.80%
7 Evaxion A 62.56 Bn 62.54 Bn - 19.97%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 47.10%
10 Silence Therapeutics 924.61 Mn 854.53 Mn 411,000.00 0.98%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.98%
Dec 31, 2025 10.05%
Sep 30, 2025 -24.00%
Jun 30, 2025 -17.41%
Mar 31, 2025 -30.48%
Dec 31, 2024 41.16%
Sep 30, 2024 -33.11%
Jun 30, 2024 -7.42%
Mar 31, 2024 44.62%
Dec 31, 2023 -2.22%
Sep 30, 2023 -3.13%